跳到内容

心胸血管外科(儿科)

止血的管理和优化

抗纤溶药物

Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (打开新窗口)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

来源‎: Anesth Analg 2006;102(3):731-7.

检索‎: PubMed 16492820

DOI码‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (打开新窗口)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (打开新窗口)

Basta MN, Stricker PA, Taylor JA.

来源‎: Pediatr Surg Int 2012;28(11):1059-69.

检索‎: PubMed 22940882

DOI码‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (打开新窗口)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (打开新窗口)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

来源‎: Br J Anaesth 2012;108(5):830-7.

检索‎: PubMed 22362670

DOI码‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (打开新窗口)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (打开新窗口)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

来源‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

检索‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (打开新窗口)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (打开新窗口)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

来源‎: Ann Thorac Surg 2000;70(4):1308-12.

检索‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (打开新窗口)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (打开新窗口)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

来源‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

检索‎: PubMed 22075061

DOI码‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (打开新窗口)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (打开新窗口)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

来源‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

检索‎: PubMed 24637029

DOI码‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (打开新窗口)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (打开新窗口)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

来源‎: PLoS One 2015;10(5):e0126514.

检索‎: PubMed 25954976

DOI码‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (打开新窗口)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (打开新窗口)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

来源‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

检索‎: PubMed 21115357

DOI码‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (打开新窗口)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (打开新窗口)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

来源‎: Br J Anaesth 2013;110(4):615-21.

检索‎: PubMed 23213034

DOI码‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (打开新窗口)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (打开新窗口)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

来源‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

检索‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (打开新窗口)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (打开新窗口)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

来源‎: Ann Card Anaesth 2015;18(1):23-6.

检索‎: PubMed 25566706

DOI码‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (打开新窗口)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (打开新窗口)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

来源‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

检索‎: PubMed 22264414

DOI码‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (打开新窗口)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (打开新窗口)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

来源‎: Eur J Anaesthesiol 2015;32(12):844-50.

检索‎: PubMed 26258658

DOI码‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (打开新窗口)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (打开新窗口)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

来源‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

检索‎: PubMed 22995453

DOI码‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (打开新窗口)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (打开新窗口)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

来源‎: Ann Card Anaesth 2010;13(2):110-5.

检索‎: PubMed 20442540

DOI码‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (打开新窗口)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (打开新窗口)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

来源‎: Anesthesiology 2015;122(4):746-58.

检索‎: PubMed 25585004

DOI码‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (打开新窗口)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (打开新窗口)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

来源‎: Ann Thorac Surg 2011;92(3):958-63.

检索‎: PubMed 21871283

DOI码‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (打开新窗口)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (打开新窗口)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

来源‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

检索‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (打开新窗口)

重组活化凝血因子VII(rFVIIa)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (打开新窗口)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

来源‎: Ann Thorac Surg 2007;84(1):161-8.

检索‎: PubMed 17588404

DOI码‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (打开新窗口)

Pediatric off-label use of recombinant factor VIIa. (打开新窗口)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

来源‎: Pediatrics 2009;123(3):1066-72.

检索‎: PubMed 19255041

DOI码‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (打开新窗口)

Factor VII for excessive bleeding following congenital heart disease surgery. (打开新窗口)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

来源‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

检索‎: PubMed 22499956

DOI码‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (打开新窗口)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (打开新窗口)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

来源‎: Paediatr Anaesth 2009;19(4):364-70.

检索‎: PubMed 19143947

DOI码‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (打开新窗口)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (打开新窗口)

Guzzetta NA, Russell IA, Williams GD.

来源‎: Anesth Analg 2012;115(2):364-78.

检索‎: PubMed 22652310

DOI码‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (打开新窗口)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (打开新窗口)

Okonta KE, Edwin F, Falase B.

来源‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

检索‎: PubMed 22811512

DOI码‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (打开新窗口)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (打开新窗口)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

来源‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

检索‎: PubMed 21924639

DOI码‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (打开新窗口)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (打开新窗口)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

来源‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

检索‎: PubMed 21835642

DOI码‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (打开新窗口)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (打开新窗口)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

来源‎: J Clin Anesth 2014;26(3):204-11.

检索‎: PubMed 24809789

DOI码‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (打开新窗口)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (打开新窗口)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

来源‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

检索‎: PubMed 22371937

DOI码‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (打开新窗口)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (打开新窗口)

Tobias JD, Berkenbosch JW, Russo P.

来源‎: Pediatr Crit Care Med 2003;4(1):49-51.

检索‎: PubMed 12656542

DOI码‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (打开新窗口)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (打开新窗口)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

来源‎: J Intensive Care Med 2004;19(5):270-3.

检索‎: PubMed 15358945

DOI码‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (打开新窗口)

Recombinant activated factor VII in cardiac surgery: a systematic review. (打开新窗口)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

来源‎: Ann Thorac Surg 2007;83(2):707-14.

检索‎: PubMed 17258029

DOI码‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (打开新窗口)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (打开新窗口)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

来源‎: Pediatr Crit Care Med 2009;10(5):572-82.

检索‎: PubMed 19451849

DOI码‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (打开新窗口)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (打开新窗口)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

来源‎: Pediatr Cardiol 2013;34(1):119-24.

检索‎: PubMed 22760694

DOI码‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (打开新窗口)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (打开新窗口)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

来源‎: Pediatr Hematol Oncol 2008;25(4):301-11.

检索‎: PubMed 18484474

DOI码‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (打开新窗口)

凝血因子浓缩剂

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (打开新窗口)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

来源‎: Artif Organs 2010;34(11):955-60.

检索‎: PubMed 21092037

DOI码‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (打开新窗口)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (打开新窗口)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

来源‎: Eur J Anaesthesiol 2014;31(6):317-26.

检索‎: PubMed 24503704

DOI码‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (打开新窗口)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (打开新窗口)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

来源‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

检索‎: PubMed 27493092

DOI码‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (打开新窗口)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (打开新窗口)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

来源‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

检索‎: PubMed 24951020

DOI码‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (打开新窗口)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (打开新窗口)

Noga T, Bruce AA, Blain H, Nahirniak S.

来源‎: Vox Sang 2016;110(3):253-7.

检索‎: PubMed 26509839

DOI码‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (打开新窗口)

局部止血药

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (打开新窗口)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

来源‎: Ann Surg 2010;251(2):217-28.

检索‎: PubMed 20010084

DOI码‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (打开新窗口)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (打开新窗口)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

来源‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

检索‎: PubMed 17669759

DOI码‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (打开新窗口)

利用血液粘弹性检测辨别外科性出血或凝血病出血

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (打开新窗口)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

来源‎: Ann Card Anaesth 2012;15(1):26-31.

检索‎: PubMed 22234018

DOI码‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (打开新窗口)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (打开新窗口)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

来源‎: Artif Organs 2010;34(11):955-60.

检索‎: PubMed 21092037

DOI码‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (打开新窗口)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (打开新窗口)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

来源‎: Br J Anaesth 2015;114(1):91-102.

检索‎: PubMed 25303988

DOI码‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (打开新窗口)